Phibro Animal Health Morgan Bond
| PAHC Stock | USD 23.59 0.02 0.08% |
Phibro Animal Health holds a debt-to-equity ratio of 1.792. At present, Phibro Animal's Net Debt To EBITDA is projected to slightly decrease based on the last few years of reporting. The current year's Interest Debt Per Share is expected to grow to 13.22, whereas Short and Long Term Debt Total is forecasted to decline to about 335.6 M. With a high degree of financial leverage come high-interest payments, which usually reduce Phibro Animal's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Phibro Animal's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Phibro Animal's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Phibro Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Phibro Animal's stakeholders.
For most companies, including Phibro Animal, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Phibro Animal Health, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Phibro Animal's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 3.6959 | Book Value 6.383 | Operating Margin 0.0811 | Profit Margin 0.0166 | Return On Assets 0.0526 |
Phibro |
Given the importance of Phibro Animal's capital structure, the first step in the capital decision process is for the management of Phibro Animal to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of Phibro Animal Health to issue bonds at a reasonable cost.
| Popular Name | Phibro Animal Morgan Stanley 3591 |
| Specialization | Pharmaceuticals, Biotechnology & Life Sciences |
| Equity ISIN Code | US71742Q1067 |
| Bond Issue ISIN Code | US61744YAK47 |
| S&P Rating | Others |
| Maturity Date | 22nd of July 2028 |
| Issuance Date | 24th of July 2017 |
| Coupon | 3.591 % |
Phibro Animal Health Outstanding Bond Obligations
| Boeing Co 2196 | US097023DG73 | Details | |
| HSBC Holdings PLC | US404280DR76 | Details | |
| MPLX LP 52 | US55336VAL45 | Details | |
| Morgan Stanley 3591 | US61744YAK47 | Details |
Understaning Phibro Animal Use of Financial Leverage
Phibro Animal's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures Phibro Animal's total debt position, including all outstanding debt obligations, and compares it with Phibro Animal's equity. Financial leverage can amplify the potential profits to Phibro Animal's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if Phibro Animal is unable to cover its debt costs.
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 525.5 M | 335.6 M | |
| Net Debt | 454.8 M | 301.8 M | |
| Long Term Debt | 458.3 M | 250.9 M | |
| Short Term Debt | 37.3 M | 18.8 M | |
| Short and Long Term Debt | 29.8 M | 30.7 M | |
| Long Term Debt Total | 520.4 M | 333.8 M | |
| Net Debt To EBITDA | 6.59 | 6.92 | |
| Debt To Equity | 1.90 | 1.81 | |
| Interest Debt Per Share | 12.59 | 13.22 | |
| Debt To Assets | 0.50 | 0.66 | |
| Long Term Debt To Capitalization | 0.64 | 0.61 | |
| Total Debt To Capitalization | 0.66 | 1.17 | |
| Debt Equity Ratio | 1.90 | 1.81 | |
| Debt Ratio | 0.50 | 0.66 | |
| Cash Flow To Debt Ratio | 0.18 | 0.19 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out the analysis of Phibro Animal Fundamentals Over Time. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.94) | Dividend Share 0.48 | Earnings Share 0.43 | Revenue Per Share 25.843 | Quarterly Revenue Growth 0.126 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.